Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Cost of Revenue: 2009-2024

Historic Cost of Revenue for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to $84.0 million.

  • Rockwell Medical's Cost of Revenue fell 38.15% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.1 million, marking a year-over-year decrease of 21.98%. This contributed to the annual value of $84.0 million for FY2024, which is 12.14% up from last year.
  • According to the latest figures from FY2024, Rockwell Medical's Cost of Revenue is $84.0 million, which was up 12.14% from $74.9 million recorded in FY2023.
  • Rockwell Medical's Cost of Revenue's 5-year high stood at $84.0 million during FY2024, with a 5-year trough of $59.5 million in FY2020.
  • For the 3-year period, Rockwell Medical's Cost of Revenue averaged around $75.9 million, with its median value being $74.9 million (2023).
  • Data for Rockwell Medical's Cost of Revenue shows a peak YoY climbed of 12.14% (in 2024) over the last 5 years.
  • Rockwell Medical's Cost of Revenue (Yearly) stood at $59.5 million in 2020, then grew by 8.20% to $64.4 million in 2021, then grew by 6.81% to $68.7 million in 2022, then increased by 8.98% to $74.9 million in 2023, then grew by 12.14% to $84.0 million in 2024.